- Title: Subtitle
- Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry
- Creators
- David A. Bond - The Ohio State UniversityJason T. Romancik - Emory UniversityJeffrey M. Switchenko - Emory UniversityBrielle Berkowitz - University of AtlantaJonathan R Day - Roy J. and Lucille A. Carver College of MedicineUmar Farooq - University of IowaSabarish Ayyappan - University of IowaKatelin Baird - Emory UniversityMichelle L. Churchman - Biogen (United States)Andrew M. Evens - 10Rutgers Cancer Institute of New Jersey, Warren, NJBijal D. Shah - Moffitt Cancer CenterCraig A. Portell - University of VirginiaKami J. Maddocks - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteBrian K. Link - University of IowaJonathon B. Cohen - Emory UniversityDeborah M. Stephens - Huntsman Cancer Institute
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.140(Supplement 1), pp.6509-6511
- DOI
- 10.1182/blood-2022-160306
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Language
- English
- Date published
- 11/15/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984361732002771
Abstract
Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry
Blood, Vol.140(Supplement 1), pp.6509-6511
11/15/2022
DOI: 10.1182/blood-2022-160306
Details
Metrics
4 Record Views